Vimarsana
Biggest News Aggregation in the World

Spirovant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Spirovant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Spirovant Sciences Today - Breaking & Trending Today

Women's workforce representation is about more than just numbers - Vimarsana News

Women's workforce representation is about more than just numbers

Creating inclusive and intentionally supporting environments is also important, said panelists at PACT’s annual Foundation Breakfast.

Sumitomo Pharma Subsidiary Companies in the U.S., Including Sumitovant and its Wholly Owned Subsidiaries, to Combine and Form Sumitomo Pharma America - Vimarsana News

Sumitomo Pharma Subsidiary Companies in the U.S., Including Sumitovant and its Wholly Owned Subsidiaries, to Combine and Form Sumitomo Pharma America

/PRNewswire/ -- Sumitovant Biopharma Ltd. ("Sumitovant") announced today that its parent company Sumitomo Pharma Co., Ltd. ("Sumitomo Pharma") will combine its...

Sumitomo Pharma Subsidiary Companies in the U.S., Including Sunovion, to Combine and Form Sumitomo P - Vimarsana News

Sumitomo Pharma Subsidiary Companies in the U.S., Including Sunovion, to Combine and Form Sumitomo P

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sunovion Pharmaceuticals Inc., an indirect, wholly owned subsidiary of Sumitomo Pharma Co. Ltd, announced today that it will combine with affiliate companies Sumitomo Pharma America Holdings, Inc., Sumitovant Biopharma Ltd., Myovant Sciences, Inc., Urovant Sciences, Inc., Enzyvan...

Roivant Sciences founder Ramaswamy considering 2024 presidential run - POLITICO (ROIV) - Vimarsana News

Roivant Sciences founder Ramaswamy considering 2024 presidential run - POLITICO (ROIV)

Vivek Ramaswamy, the founder and former CEO of Roivant Sciences (ROIV), is considering a bid for the Republican presidential nomination, POLITICO reported.

World CFTR Modulators Market Insights: Current, Regional and Future Outlook 2028: > $25 Billion Market Opportunity, >30 Pipeline Drugs - Vimarsana News

World CFTR Modulators Market Insights: Current, Regional and Future Outlook 2028: > $25 Billion Market Opportunity, >30 Pipeline Drugs

/PRNewswire/ -- The "Global CFTR Modulators Market Opportunity, Dosage, Price & Clinical Trials Insight 2028" report has been added to ResearchAndMarkets.com's...